Lastly, RelB/p52 can regulate the transcriptional suppressor EZH2 which inhibits transcription of well-known tumor suppressors (p16Ink4a and p14ARF) and p53 target genes [17] in a variety of cancer types. Here, CDKN2A is linked to neoplasm.